Additional Therapeutic Applications
Navitor’s discovery efforts, both proprietary and partnered, will leverage the potential to selectively modulate mTORC1 activity to address diseases that are caused by dysfunctional mTOR activity.
Navitor’s discovery efforts, both proprietary and partnered, will leverage the potential to selectively modulate mTORC1 activity to address diseases that are caused by dysfunctional mTOR activity.